ClinicalTrials.Veeva

Menu

The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

Hackensack Meridian Health logo

Hackensack Meridian Health

Status

Terminated

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT00481585
07.01.041

Details and patient eligibility

About

The objective of the present study is to determine whether or not primary human mammary epithelial cells are competent for use in molecular studies of transepithelial electrophysiology focusing on the function of the tight junction protein claudin 3.

Human breast Tissue will be removed from mastectomy specimens and used as a source to generate epithelial cells for study.

Enrollment

13 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects of this pilot study are limited to those female patients who are undergoing therapeutic or prophylactic mastectomy procedures conducted by the department of Surgery at HUMC.

Exclusion criteria

  • From within this population, no exclusion criteria shall be applied based on age, race, ethnicity, gender, HIV status, or menopause.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems